about
Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissuesEndogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathyHypertension and heart failure: role of neurohormonal mechanisms.Vasoactive peptides in cardiovascular (patho)physiology.Pravastatin ameliorates placental vascular defects, fetal growth, and cardiac function in a model of glucocorticoid excess.Atrial natriuretic peptide increases inflammation, infarct size, and mortality after experimental coronary occlusion.Natriuretic peptides in cardiovascular diseases: current use and perspectivesDiscovering a new role for the atrial natriuretic peptide: A novel risk factor for cardiovascular diseases.Atrial natriuretic peptide effects on intracellular pH changes and ROS production in HEPG2 cells: role of p38 MAPK and phospholipase D.Differential sensitivity of human monocytes and macrophages to ANP: a role of intracellular pH on reactive oxygen species production through the phospholipase involvement.Inhibition of NHE-1 Na+/H+ exchanger by natriuretic peptides in ocular nonpigmented ciliary epithelium.High NT-proBNP is a strong predictor of outcome in elderly heart failure patients.Switch from actin alpha1 to alpha2 expression and upregulation of biomarkers for pressure overload and cardiac hypertrophy in taurine-deficient mouse heart.Effect of AT2 blockade on cardiac hypertrophy as induced by high dietary salt in the proatrial natriuretic peptide (ANP) gene-disrupted mouse.Effects of atrial natriuretic peptide on the extrasplenic microvasculature and lymphatics in the rat in vivo.
P2860
Q28550738-FD5A7F51-E905-43FA-8CA7-D55607AFE9B0Q34605877-6FC96990-EA1F-445F-8157-8DE7C9553290Q35791763-783AD5C2-4AA3-47C6-989F-1099A9C03E0AQ36035785-0B08569B-0238-4C02-9F65-7D8B4BD91409Q36815987-C5B9A68A-CD9D-4891-87DC-EAD5DCA8C618Q36978198-62D9B80B-0539-40AF-8EAF-15484BFFDA16Q37138941-EE753A3A-F8BE-4B8F-BC6F-6C2CFF1B0493Q38162429-29578F61-7B63-49F1-8BC7-6090C859393CQ38605411-562CD544-B0AE-4205-A1E3-829C955D6572Q40467054-4A9B19DF-B650-461D-AE3D-5FF80CC62E28Q44378757-EA1A2E4A-48E2-4A58-B4C1-A8A1842DD3B6Q44894349-0A17E760-CF7C-4757-A4A3-37697FACD1BAQ46823675-10BDD4BE-B2B4-4A73-A227-F3E5B55AE4FAQ48380316-9E70DB16-7044-44FD-B048-AA024FB1D433Q48450592-A494DF0F-FD14-4E02-A4A7-39F2369AF699Q53868801-D3D7D27D-F4ED-4730-A437-3BD99918773D
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The atrial natriuretic peptide: a changing view.
@ast
The atrial natriuretic peptide: a changing view.
@en
The atrial natriuretic peptide: a changing view.
@nl
type
label
The atrial natriuretic peptide: a changing view.
@ast
The atrial natriuretic peptide: a changing view.
@en
The atrial natriuretic peptide: a changing view.
@nl
prefLabel
The atrial natriuretic peptide: a changing view.
@ast
The atrial natriuretic peptide: a changing view.
@en
The atrial natriuretic peptide: a changing view.
@nl
P1476
The atrial natriuretic peptide: a changing view.
@en
P2093
P304
P356
10.1097/00004872-200111000-00001
P577
2001-11-01T00:00:00Z